Dorothy R. Auth Ph.D.

Phone212 504 6018

Peer Rating
N/R
 N/R

Client Rating

Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials
 

Practice Areas

  • Health Care
  • IP Due Diligence
  • ITC Litigation
  • Intellectual Property
  • Litigation
  • Patent & Trade Secret Litigation
  • Patent Preparation & Prosecution
  • Trademark & Copyright Protection
 
Contact InfoTelephone: 212 504 6018
Fax: 212 504 6666
http://www.cadwalader.com/professionals/dorothy-auth
 
University Rutgers University, B.A., 1985; Tufts University Ph.D.
 
Law SchoolSt. John's University School of Law, J.D., 1996
 
Admitted1996, New Jersey; 1997, New York; U.S. Court of Appeals for the Federal Circuit; U.S. Court of Appeals, 2nd Circuit; U.S. District Court, District of New Jersey; U.S. District Court, Eastern District of New York; U.S. District Court, Southern District of New York
 
Biography

Dr. Dorothy Auth has more than 20 years of experience in complex patent litigation, as well as licensing, patent procurement, and intellectual property counseling in the United States and abroad. Her experience spans diverse industries, including biotechnology, pharmaceutical, and medical devices, as well as consumer products, computers, and other mechanical devices.

Dorothy addresses intellectual property diligence issues surrounding mergers, acquisitions, and bankruptcies. Representative clients in transactional IP matters includes the U.S. Treasury, Pfizer; Elan Pharmaceutical, Healthcare Royalty Partners; Fountanbleu Hotel; Quart Rx Pharma; iShares; Towers Watson; Hess and Triarco. In the transactional area, Dorothy advises clients on the validity of target patents as well as performing clearance analysis on the patents of competitors to render freedom-to-operate opinions.

Dorothy also litigates in U.S. Federal Courts and in international arbitrations conducted under the WIPO rules. She conducts all aspects of litigation, including motion practice, expert preparation and all aspects of discovery practice. Representative litigation clients include Medinol, DuPont, Osteonics, and Kanzaki.

Dorothy also coordinates global patent procurement and enforcement strategies for her clients to maximize their patent-protected field. In this area, Dorothy's practice includes U.S. and international client counseling regarding IP matters. Her international experience includes coordinating patent infringement trials and hearings as between the U.S. and different European jurisdictions including trials seeking preliminary relief and cross-border injunctions, as well as nullity, cancellation, and oppositions proceedings on patent rights.

Among the clients Dorothy has counseled are Credit Suisse, Rhone-Poulenc Rohrer, Inc., BioRest Ltd., Oscillon Ltd., Digene Corporation, Hoffmann-La Roche, and the National Institutes of Health.

At the firm, Dorothy is the Partner Chair of the Women's Leadership Initiative. In addition, Dorothy is a member of the Technology Committee, the Healthcare Industry Team and the Advisory Counsel for the firm's Center for Career Advancement.

Dorothy is the President Elect of the New York Intellectual Property Law Association as well as the Board Liaison to the Strategic Planning Committee and the Women in IP Law Committee. She is also a member of the American Intellectual Property Association and the Intellectual Property Owner's Association.

Dorothy is a frequent speaker on a wide variety of topics including:
•Update in Reverse Payment Settlements after Actavis
•Post Grant Review and Inter Partes Proceedings
•Annual Update in Biotech/Pharama Patent Law - PLI
•Patent Eligibility under 101 for Biotechnology

Prior to joining Cadwalader, she was a partner with Morgan & Finnegan, an intellectual property specialty firm in New York.

Dorothy earned her J.D. from St. John's School of Law, a Ph.D. in biochemistry from Tufts Medical School, and her B.A. in biochemistry from Cook College of Rutgers University.

Dorothy is admitted to practice in New York and New Jersey and before the U.S. District Courts for the Southern and Eastern Districts of New York and the District of New Jersey, and the U.S. Courts of Appeals for the Second and Federal Circuits. She is also licensed to practice before the U.S. Patent and Trademark Office.

News & Resources

NEWS

News Releases

Cadwalader Advises Acorda Therapeutics on Merger Agreement to Acquire Civitas Therapeutics

Sep 24, 2014

Cadwalader Advises Forbes Media LLC on Majority Stake Sale to International Investors

Jul 18, 2014

Cadwalader Named to Winner's Circle at M&A Atlas Awards

Feb 24, 2010

Cadwalader Transaction Named IDD Deal of the Year

Feb 12, 2010

Cadwalader Attorneys Honored with Burton Award for Excellence in Legal Writing for Sixth Time

Jun 02, 2009

Recent Press

New Deals - Lawyers on Major Transactions

Jan 29, 2009

A Long Weekend for Cadwalader, Simpson and Wachtell

Jan 26, 2009

RESOURCES

Clients & Friends Memos

New Decision Increases Calculation of Patent Term

Jan 16, 2014

Supreme Court Decision Compels Brand-Name and Generic Drug Manufacturers Alike to Rethink Hatch-Waxman Litigation Strategies

Jun 18, 2013

Articles

Final Patent Rules Quell Jitters Over Post-Grant Proceedings

Oct 11, 2012

Congressional Breakthrough On Patent Reform Likely This Fall

Sep 14, 2011

Federal Circuit Considers 'Inequitable Conduct' En Banc

Aug 16, 2010

Global Patent Strategy

Oct 26, 2009

Newsletter

IP Insight

International Trade Commission

ITC Proposed New Procedures for Electronic Filing

Sep 26, 2011

ITC Opinion Sets Standards for Analyzing Portfolio Licenses and the Domestic Industry Requirement

Sep 26, 2011

Electronic Discovery at the ITC: Current Challenges And Possible Improvements

Sep 26, 2011

ITC Chief Administrative Law Judge Paul J. Luckern Retires

Sep 26, 2011

ITC Delegating to ALJs Fact Finding Responsibilities on Public Interest

May 09, 2011

Federal Circuit Review of ITC Determinations: General Protecht Group, Inc. v. ITC and Vizio, Inc. v. ITC

May 09, 2011

Federal Circuit Decision in GE v. ITC re: Allocation of Argument Time in Favor of Intervenors Rather Than ITC

May 09, 2011

ITCTLA Trip to Beijing, Nanjing, Shanghai and Guangzhou, China on May 23-27, 2011 to Present a Program on Section 337 Proceedings Before The U.S. International Trade Commission

May 09, 2011

ITC Litigation & Enforcement Conference Held in New York on February 23-24, 2011 -- Summary of Judges' Panel on “The View from the Bench”

May 09, 2011

More Insight On ITC Claim Construction Procedures From The ITC Investigation of Certain Digital Set-Top Boxes And Components Thereof, Inv. No. 337-TA-712

Feb 14, 2011

Federal Circuit Addresses Multiple Issues In Affirming The Commission's Final Determination In Spansion, Inc. v. International Trade Commission

Feb 14, 2011

ITC Publishes Study on Chinese Intellectual Property Infringement

Feb 14, 2011

ITC Proposes New Pleading Rules to Address Public Interest Issues

Nov 22, 2010

ITC Urges Federal Circuit to Refrain from Deciding Section 337 Appeals on Grounds “Not Presented” by the Parties

Nov 22, 2010

New ITC Procedure for Public Release of Final ITC Decisions on the Merits of Section 337 Cases

Nov 22, 2010

Review of SEB S.A. v. Montgomery Ward & Co. and Recent Section 337 Investigations Involving Inducement

Nov 22, 2010

Inaugural Quarterly Meeting with James Holbein, Supervisory Attorney-Advisor, and Lisa Barton, Attorney-Advisor, of ITC Docket Services, Office Of Information Technology Services

Nov 22, 2010

Important New Decision by United States International Trade Commission on the Procedure for Pretrial Claim Construction in Section 337 Investigations

Nov 22, 2010

ITC Investigations Not Subject To Bankruptcy Stays -- District Court Decisions Reverse Bankruptcy Court Stays Of ITC Investigations 648 And 685

Sep 24, 2010

ITC Domestic Industry Requirement - ITC Opinion In Coaxial Cable Connectors Case Outlines Standard For Demonstrating A “Domestic Licensing Industry” By Non-Practicing Entities

Sep 24, 2010

ITC Judge E. James Gildea Joins The Ranks Of ITC Judges Holding Pre-Trial Markman Hearings

Sep 24, 2010

ITC's Mediation Program For Section 337 Investigations Gaining Momentum

Sep 24, 2010

ITC Reviews First Ever Markman Claim Construction Made By Summary Determination

Sep 24, 2010

IP Czar Aims At Enhancing Section 337 Enforcement Of IP Rights

Sep 24, 2010

ITC To Solicit Public Interest Comments Upon Receipt Of Complaint

Sep 24, 2010

U.S. Federal Courts

Supreme Court, in FTC v. Actavis, Rejects the “Scope of the Patent” Test, Holding that Antitrust Law's “Rule of Reason” Analysis Can Pierce the Shield of Patent Rights

Jul 09, 2013

Supreme Court Rules that a Naturally Occurring DNA Segment Is Not Patent Eligible, But cDNA May Be Patent Eligible

Jul 09, 2013

The Federal Circuit Has Jurisdiction over Appeals in Which Damages and Willfulness Remain Unresolved

Jul 09, 2013

Federal Circuit Clarifies Standards for a Clinical Trial to Be Public Use

Jul 09, 2013

Federal Circuit Rules on Patentability of Business Method Patent

Jul 09, 2013

Federal Circuit Opens Reissue Proceedings to Add New Claims to Hedge Against Patent Invalidity

Sep 26, 2011

Federal Circuit Holds Isolated DNA Is Statutory Subject Matter Under s101

Sep 26, 2011

Prometheus Redux

Sep 26, 2011

In Section 145 Civil Actions, Patent Applicants Are Not Limited To The PTO Record and May Introduce New Evidence

Jul 14, 2011

En Banc Federal Circuit Overhauls Inequitable Conduct Law

Jul 14, 2011

Supreme Court Rules that Clear and Convincing Evidence Is Required to Establish the Invalidity of a Patent

Jul 14, 2011

En Banc Federal Circuit To Review Joint (Divided) Infringement

Jul 14, 2011

Supreme Court Rules that Induced Infringement Under Section 271(b) Requires Knowledge or 'Willful Blindness' that the Induced Acts Constitute Patent Infringement

Jul 14, 2011

Rule 9(b) Applies To The False Marking Statute

May 09, 2011

Largest Patent Infringement Verdict Ever Affirmed On Appeal

Feb 14, 2011

Supreme Court To Review The 27 Year Old Clear and Convincing Evidence Requirement for Invalidity

Feb 14, 2011

Federal Circuit Applies Bilski And Reaffirms Decision That Methods Of Optimizing Drug Dosages Are Patentable Under 35 U.S.C. 101

Feb 14, 2011

Federal Circuit Requires Principal/Agent Relationship or Contractual Obligation for Joint Infringement

Feb 14, 2011

Federal Circuit Reverses Judgment that Insurance Companies Infringed Patent on Computerized Method for Administering Variable Annuities

Nov 22, 2010

Federal Circuit Approves Use Of Industry Standards To Prove Infringement

Nov 22, 2010

The Supreme Court Grants Certiorari to Determine the Intent Required for Inducement of Infringement - Its Tenth Patent Case Since 2005

Nov 22, 2010

Supreme Court To Review Rights to Inventions Arising From Federally-Funded Research

Nov 22, 2010

En Banc Decision by Federal Circuit Addresses Scope of Patent Misuse Doctrine

Nov 22, 2010

Federal Circuit Addresses Definiteness Requirement For Means-Plus-Function Claims

Nov 22, 2010

The Federal Circuit Sets Forth Standards for Protective Orders Containing a Patent Prosecution Bar

Sep 24, 2010

Preserve Your Claims, or Else - The Federal Circuit Warns - You Will Not Get “A Second Bite” At The Apple

Sep 24, 2010

Plaintiffs in “Myriad Genetics” Case Move for Recusal of Chief Judge Rader

Sep 24, 2010

District Court Dismisses False Marking Actions Based On Plaintiff's Failure To Meet Heightened Pleading Standard of Federal Rule of Civil Procedure 9(b)

Sep 24, 2010

Federal Circuit Rejects Accused Infringer's “Divided Infringement” and Standing Defenses; Holds Claims Cover Patent-Eligible Subject Matter

Sep 24, 2010

“Plain Errors” In Jury Instructions, Verdict Form, Require New Trial On Individual Liability For Corporation's Infringement; Damage Award Vacated As Product Of “Speculation Or Guesswork”

Sep 24, 2010

Recent Federal Circuit Decision May Affect Inequitable Conduct Determinations

Jul 13, 2010

Applying Inwood to Online Market Place, Second Circuit Finds Generalized Knowledge of Counterfeiting Insufficient for Contributory Trademark Infringement

Jul 13, 2010

District Court Rules That Isolated Genes Are Unpatentable Products Of Nature

Jul 13, 2010

Without Affirmative Act By Patentee, Federal Circuit Rejects Declaratory Judgment Suit By Potential Infringer

Jul 13, 2010

Patent Held Unenforceable On Grounds Of Equitable Estoppel

Jul 13, 2010

Federal Circuit Affirms En Banc a Separate Written Description Requirement under 35 U.S.C. 112, Paragraph 1

Jul 13, 2010

Implied Assertion of Rights by Patent Licensing Company Supports Declaratory Judgment Jurisdiction

Jul 13, 2010

Videos

VS.: Interview with FBI Anti-trafficking Unit

Dec 11, 2012

 
ISLN911259054
 

Documents by this lawyer on Martindale.com

Subscribe to this feed

New Decision Increases Calculation of Patent Term
Dorothy R. Auth,Andrew C. Chien, January 22, 2014
Yesterday, in Novartis AG v. Lee, 2013-1160 (Fed. Cir., Jan. 15, 2014), the Federal Circuit determined that the USPTO has been incorrectly calculating patent term adjustments, potentially shortening the terms of thousands of U.S. patents. Recently issued U.S. patents should be reviewed as soon as...
Profile Visibility
#1,001 in weekly profile views out of 96,212 lawyers in New York, New York
#15,877 in weekly profile views out of 1,616,736 total lawyers Overall

Office Information

Dorothy R. Auth Ph.D.


New YorkNY 10281-0006




Loading...
 

Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now